Nov 22 |
Top US Dividend Stocks To Consider In November 2024
|
Nov 22 |
Exclusive-US FDA finds widely used asthma drug impacts the brain
|
Nov 22 |
The Zacks Analyst Blog Highlights Broadcom, Merck, Qualcomm and Natural Health
|
Nov 21 |
Top Analyst Reports for Broadcom, Merck & Qualcomm
|
Nov 21 |
Optimism over global healthcare sector rises: Jefferies
|
Nov 21 |
Merck & Co., Inc. (MRK) Jefferies London Healthcare Conference
|
Nov 21 |
Merck Data at the ASH 2024 Annual Meeting Highlights Promising Hematology Pipeline With Diverse Range of Investigational Assets and Novel Modalities
|
Nov 21 |
Keytruda represents almost half of Merck’s sales, and a new formulation could fend off rivals
|
Nov 20 |
Merck Foundation Announces $17 Million U.S. Initiative To Expand Access to High-Quality Cardiac Care
|
Nov 20 |
Merck & Co., Inc. (MRK)’s Blockbuster Drugs: A Key Player in Ken Griffin’s Portfolio
|